Coeurative Overview
- Year Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$400K
Coeurative General Information
Description
Operator of a biotechnology company intended to develop curative strategies for the management of cardiovascular diseases related to cellular hypoxia. The company's products are activated by the level of oxygen in cells and facilitate beneficial responses in the inner lining of the blood vessels in response to cardiovascular diseases associated with oxygen-mediated stresses, enabling doctors to reduce the incidence of myocardial infarction in patients with coronary diseases.
Contact Information
Website
www.coeurative.comCorporate Office
- 201 Mcclanahan Street Southwest
- Roanoke, VA 24014
- United States
Corporate Office
- 201 Mcclanahan Street Southwest
- Roanoke, VA 24014
- United States
Coeurative Timeline
Coeurative Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 02-Apr-2024 | $400K | Completed | Generating Revenue | ||
| 4. Seed Round | 29-Sep-2022 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 07-Oct-2020 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 03-Nov-2017 | $100K | $220K | Completed | Generating Revenue | |
| 1. Angel (individual) | 20-May-2013 | $120K | $120K | Completed | Generating Revenue |
Coeurative Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Coeurative Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Coeurative Patents
Coeurative Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210346335-A1 | Methods of using nitric oxide donor compounds for treatment of covid-19 and other infectious diseases | Active | 28-Mar-2020 | ||
| EP-4126221-A2 | Novel methods of using nitric oxide donor compounds for treatment of covid-19 and other infectious diseases | Pending | 28-Mar-2020 | ||
| JP-2023519391-A | Novel methods of using nitric oxide donor compounds to treat covid-19 and other infectious diseases | Pending | 28-Mar-2020 | ||
| AU-2021246735-A1 | Novel methods of using nitric oxide donor compounds for treatment of covid-19 and other infectious diseases | Pending | 28-Mar-2020 | ||
| CA-3173143-A1 | Novel methods of using nitric oxide donor compounds for treatment of covid-19 and other infectious diseases | Pending | 28-Mar-2020 | A61K31/34 |
Coeurative FAQs
-
When was Coeurative founded?
Coeurative was founded in 2012.
-
Where is Coeurative headquartered?
Coeurative is headquartered in Roanoke, VA.
-
What industry is Coeurative in?
Coeurative’s primary industry is Biotechnology.
-
Is Coeurative a private or public company?
Coeurative is a Private company.
-
What is Coeurative’s current revenue?
The current revenue for Coeurative is .
-
How much funding has Coeurative raised over time?
Coeurative has raised $1.12M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
